welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
- Bon Voyage: Traveling with a J-Pouch Part 2https://www.youtube.com/watch?v=x-9gR_LK...
- Prospective Randomized Study of Sulindac versus Calcium and Calciferol for Upper Gastrointestinal Polyps in Familial...Eighteen patients with familial adenomat...
- Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsThe purpose of this registry is to colle...
- Combination Treatment with Curcumin and Quercetin of Adenomas in Familial Adenomatous PolyposisBACKGROUND & AIMS : Familialadenomat...
- Ileal Pouch Anal Anastomosis: Analysis of Outcome and Quality of Life in 3707 PatientsBACKGROUND : Ileal pouch anal anastomosi...
- Familial Polyposis and Lynch Syndrome Review March 2014http://www.slideshare.net/douglasriegert...
- Cancer Prevention Pharmaceuticals (CPP) and Mallinckrodt Announce Results from Pivotal Phase 3 Trial of CPP-1X/Sulin...Cancer Prevention Pharmaceuticals, Inc.,...
English
Portuguese